APA (7th ed.) Citation

SH, H., SE, Y., SP, H., B, K., P, M., HV, E., . . . JA, T. (2014). Pharmacokinetic modeling optimizes inhibition of the 'undruggable' EWS-FLI1 transcription factor in Ewing Sarcoma. Oncotarget, 5(2), 338. https://doi.org/10.18632/oncotarget.1495

Chicago Style (17th ed.) Citation

SH, Hong, et al. "Pharmacokinetic Modeling Optimizes Inhibition of the 'Undruggable' EWS-FLI1 Transcription Factor in Ewing Sarcoma." Oncotarget 5, no. 2 (2014): 338. https://doi.org/10.18632/oncotarget.1495.

MLA (9th ed.) Citation

SH, Hong, et al. "Pharmacokinetic Modeling Optimizes Inhibition of the 'Undruggable' EWS-FLI1 Transcription Factor in Ewing Sarcoma." Oncotarget, vol. 5, no. 2, 2014, p. 338, https://doi.org/10.18632/oncotarget.1495.